Virtus Health engaged Buchan to develop a comprehensive investor and public relations program for their corporate brand and support the Company through a number of major announcements. As the largest IVF provider in Australia, and the first to list on the ASX, Buchan has been able to capitalise on investor and media interest, and position the Company as a leader in a sector with high barriers to entry, through announcements such as the acquisition of SIMS IVF in Ireland in June 2014.

Buchan was able to provide Virtus with a comprehensive strategy and support around the SIMS IVF and Singapore acquisition announcements, encompassing immediate media outreach, internal communications, direct analyst and investor engagement, and conference call and presentation support. In addition we have enabled investor site tours for the company to promote understanding of the workings of the complex business of IVF, and an overarching strategy to assist Virtus in best capitalising on announcements.

Highlights

  • Supported through two major international acquisitions.
  • Provided quality investor engagement through interactive site tours and conferences.
  • Excellent media coverage in the Australian Financial Review, The Australian, The Age and Sydney Morning Herald, et al.